Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 8/2020

27.03.2020 | Original Article

Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014

verfasst von: Ping Yang, Yunbo Chen, Saiping Jiang, Ping Shen, Xiaoyang Lu, Yonghong Xiao

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

This study sought to discuss the correlation between the third-generation cephalosporins (3GC)-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption intensity from 143 Chinese tertiary hospitals in 2014. With a retrospective design, the correlation between antibiotic consumption and 3GC-resistant E. coli and K. pneumoniae were performed. 3GC-resistant E. coli was significantly correlated with the consumption of all antibiotics (r = 0.252, p < 0.01), β-Lactams antibiotics (r = 0.313, p < 0.01), β-Lactams excluding combinations with β-lactamase inhibitors (r = 0.365, p < 0.01), cephalosporin (r = 0.398, p < 0.01), cephalosporins excluding combinations with β-lactamase inhibitors (r = 0.374, p < 0.01), 3GC (r = 0.321, p < 0.01), and 3GC excluding combinations with β-lactamase inhibitors (r = 0.343, p < 0.01). 3GC-resistant K. pneumoniae was significantly correlated with the consumption of all antibiotics (r = 0.200, p < 0.05), β-Lactams antibiotics (r = 0.232, p < 0.01), cephalosporin (r = 0.215, p < 0.05), 3GC (r = 0.383, p < 0.01), 3GC excluding combinations with β-lactamase inhibitors (r = 0.245, p < 0.01), and β-lactam-β-lactamase inhibitor combinations (r = 0.218, p < 0.05). There was a significant relationship between the antibiotic consumption and the rates of 3GC-resistant E. coli and K. pneumoniae. Clinicians should grasp the indication of antibiotics use to reduce the production of drug-resistant bacteria.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Temkin E, Fallach N, Almagor J et al (2018) Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. Lancet Glob Health 6:e969–e979CrossRef Temkin E, Fallach N, Almagor J et al (2018) Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. Lancet Glob Health 6:e969–e979CrossRef
2.
Zurück zum Zitat Hwang AY, Gums JG (2016) The emergence and evolution of antimicrobial resistance: impact on a global scale. Bioorg Med Chem 24:6440–6445CrossRef Hwang AY, Gums JG (2016) The emergence and evolution of antimicrobial resistance: impact on a global scale. Bioorg Med Chem 24:6440–6445CrossRef
3.
Zurück zum Zitat Stewardson AJ, Allignol A, Beyersmann J et al (2016) The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Euro Surveill 21:30319CrossRef Stewardson AJ, Allignol A, Beyersmann J et al (2016) The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Euro Surveill 21:30319CrossRef
4.
Zurück zum Zitat Alvarez-Uria G, Gandra S, Mandal S et al (2018) Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. Int J Infect Dis 68:50–53CrossRef Alvarez-Uria G, Gandra S, Mandal S et al (2018) Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. Int J Infect Dis 68:50–53CrossRef
5.
Zurück zum Zitat Heng ST, Chen SL, Wong JGX et al (2018) No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia. Sci Rep 8:12785CrossRef Heng ST, Chen SL, Wong JGX et al (2018) No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia. Sci Rep 8:12785CrossRef
6.
Zurück zum Zitat de Kraker ME, Wolkewitz M, Davey PG et al (2011) Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 66:398–407CrossRef de Kraker ME, Wolkewitz M, Davey PG et al (2011) Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 66:398–407CrossRef
7.
Zurück zum Zitat Marchaim D, Gottesman T, Schwartz O et al (2010) National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 54:5099–5104CrossRef Marchaim D, Gottesman T, Schwartz O et al (2010) National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 54:5099–5104CrossRef
8.
Zurück zum Zitat de Kraker ME, Davey PG, Grundmann H et al (2011) Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 8:e1001104CrossRef de Kraker ME, Davey PG, Grundmann H et al (2011) Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 8:e1001104CrossRef
9.
Zurück zum Zitat Yang P, Chen Y, Jiang S et al (2018) Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrob Resist Infect Control 19:137CrossRef Yang P, Chen Y, Jiang S et al (2018) Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrob Resist Infect Control 19:137CrossRef
10.
Zurück zum Zitat Rotty J, Hoy J (2008) New therapeutic agents in the management of HIV: an overview of darunavir for clinicians. Sex Health 5:235–241CrossRef Rotty J, Hoy J (2008) New therapeutic agents in the management of HIV: an overview of darunavir for clinicians. Sex Health 5:235–241CrossRef
11.
Zurück zum Zitat Meyer E, Gastmeier P, Deja M et al (2013) Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol 303:388–395CrossRef Meyer E, Gastmeier P, Deja M et al (2013) Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol 303:388–395CrossRef
12.
Zurück zum Zitat Gbaguidi-Haore H, Dumartin C, L'Hériteau F et al (2013) Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes. J Antimicrob Chemother 68:461–470CrossRef Gbaguidi-Haore H, Dumartin C, L'Hériteau F et al (2013) Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes. J Antimicrob Chemother 68:461–470CrossRef
13.
Zurück zum Zitat Meyer E, Schwab F, Schroeren-Boersch B et al (2010) Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 14:R113CrossRef Meyer E, Schwab F, Schroeren-Boersch B et al (2010) Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit Care 14:R113CrossRef
14.
Zurück zum Zitat Daoud Z, Salem-Sokhn E, Dahdouh E et al (2017) Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals. J Glob Antimicrob Resist 11:45–51CrossRef Daoud Z, Salem-Sokhn E, Dahdouh E et al (2017) Resistance and clonality in Escherichia coli and Klebsiella spp. and relationship with antibiotic consumption in major Lebanese hospitals. J Glob Antimicrob Resist 11:45–51CrossRef
15.
Zurück zum Zitat Wushouer H, Zhang ZX, Wang JH et al (2018) Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: based on a 3 year surveillance data, 2014-2016. J Infect Public Health 11:339–346CrossRef Wushouer H, Zhang ZX, Wang JH et al (2018) Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: based on a 3 year surveillance data, 2014-2016. J Infect Public Health 11:339–346CrossRef
16.
Zurück zum Zitat Hsueh PR, Chen WH, Luh KT (2005) Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26:463–472CrossRef Hsueh PR, Chen WH, Luh KT (2005) Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26:463–472CrossRef
17.
Zurück zum Zitat Peirano G, Pitout JDD (2019) Extended-Spectrum β-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options. Drugs 79:1529–1541CrossRef Peirano G, Pitout JDD (2019) Extended-Spectrum β-lactamase-producing Enterobacteriaceae: update on molecular epidemiology and treatment options. Drugs 79:1529–1541CrossRef
18.
Zurück zum Zitat Padmini N, Ajilda AAK, Sivakumar N et al (2017) Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern. J Basic Microbiol 57:460–470 Padmini N, Ajilda AAK, Sivakumar N et al (2017) Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern. J Basic Microbiol 57:460–470
19.
Zurück zum Zitat Quan J, Zhao D, Liu L et al (2017) High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother 72:273–280CrossRef Quan J, Zhao D, Liu L et al (2017) High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother 72:273–280CrossRef
20.
Zurück zum Zitat Nakai H, Hagihara M, Kato H et al (2016) Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. J Infect Chemother 22:319–326CrossRef Nakai H, Hagihara M, Kato H et al (2016) Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. J Infect Chemother 22:319–326CrossRef
21.
Zurück zum Zitat Chopra T, Marchaim D, Johnson PC et al (2015) Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: a focus on antimicrobials including cefepime. Am J Infect Control 43:719–723CrossRef Chopra T, Marchaim D, Johnson PC et al (2015) Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: a focus on antimicrobials including cefepime. Am J Infect Control 43:719–723CrossRef
Metadaten
Titel
Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014
verfasst von
Ping Yang
Yunbo Chen
Saiping Jiang
Ping Shen
Xiaoyang Lu
Yonghong Xiao
Publikationsdatum
27.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 8/2020
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-03856-1

Weitere Artikel der Ausgabe 8/2020

European Journal of Clinical Microbiology & Infectious Diseases 8/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.